Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMF in Merkel Cell Carcinoma
NCT00003549Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 1998
- Primary completion
- Sep 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, methotrexate, fluorouracil in Merkel cell carcinoma (MCC), sponsored by SWOG Cancer Research Network. Started Oct 1998; status: completed.
02
Drugs
cyclophosphamidemethotrexatefluorouracil
03
Conditions
Merkel cell carcinoma (MCC)
Beyond the preview
Go deeper on NCT00003549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003549.